ASCT Benefited Younger, Older Multiple Myeloma Patients Equally, Study Finds – Myeloma Research News
Myeloma Research News |
ASCT Benefited Younger, Older Multiple Myeloma Patients Equally, Study Finds
Myeloma Research News Multiple myeloma patients older than 65 years benefit as much as younger patients from autologous stem cell transplant (ASCT), according to a recent retrospective study. But although the study showed that progression-free survival (PFS) is as good in … |
